{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:31:23Z","timestamp":1775208683822,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00103-019-02975-1","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T09:02:35Z","timestamp":1560243755000},"page":"861-869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Medikament\u00f6se Sekund\u00e4rpr\u00e4vention bei Frauen und M\u00e4nnern mit koronarer Herzkrankheit in Deutschland zwischen 1997\u20131999 und 2008\u20132011 \u2013 Trendanalyse mit Daten zweier bundesweiter Gesundheitssurveys","Secondary prevention of coronary heart disease in women and men in Germany from 1997\u20131999 and from 2008\u20132011\u2014Trend analysis with two national health population surveys"],"prefix":"10.1007","volume":"62","author":[{"given":"Hildtraud","family":"Knopf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Grams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Scheidt-Nave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Sarganas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"2975_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937\u2013952","journal-title":"Lancet"},{"key":"2975_CR2","volume-title":"The top 10 causes of death. Factsheet no. 310, updated June 2011","author":"WHO","year":"2016","unstructured":"WHO (2016) The top 10 causes of death. Factsheet\u00a0310, updated May 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death . Zugegriffen: 03.06.2019"},{"key":"2975_CR3","volume-title":"Nationale VersorgungsLeitlinie Chronische KHK","author":"Bundes\u00e4rztekammer","year":"2016","unstructured":"Bundes\u00e4rztekammer, Kassen\u00e4rztliche Bundesvereinigung, Fachgesellschaften ADWM (2016) Nationale VersorgungsLeitlinie Chronische KHK"},{"key":"2975_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s003920050148","volume":"87","author":"J Meyer","year":"1998","unstructured":"Meyer J, Breithardt G, Erbel R, Erdmann E, Gohlke H, Hanrath P et\u00a0al (1998) Leitlinie: Koronare Herzkrankheit \/ Angina Pectoris. Z\u00a0Kardiol 87:907\u2013911","journal-title":"Z Kardiol"},{"key":"2975_CR5","volume-title":"Nationale VersorgungsLeitlinie Chronische KHK Version 1.2","author":"Bundes\u00e4rztekammer","year":"2006","unstructured":"Bundes\u00e4rztekammer, Kassen\u00e4rztliche Bundesvereinigung, Fachgesellschaften ADWM (2006) Nationale VersorgungsLeitlinie Chronische KHK Version 1.2. https:\/\/www.leitlinien.de\/mdb\/downloads\/nvl\/khk\/archiv\/khk-2aufl-vers1-lang.pdf . Zugegriffen: 17.10.2018"},{"key":"2975_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/02813430310000546","volume":"21","author":"P Nilsson","year":"2003","unstructured":"Nilsson P, Brandstrom H, Lingfors H et\u00a0al (2003) Gender differences in secondary prevention of coronary heart disease: reasons to worry or not? Scand J Prim Health Care 21:37\u201342","journal-title":"Scand J Prim Health Care"},{"key":"2975_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/14017430500233417","volume":"39","author":"A Kattainen","year":"2005","unstructured":"Kattainen A, Salomaa V, Jula A et\u00a0al (2005) Gender differences in the treatment and secondary prevention of CHD at population level. Scand Cardiovasc\u00a0J 39:327\u2013333","journal-title":"Scand Cardiovasc J"},{"key":"2975_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11606-007-0116-5","volume":"22","author":"AR Opotowsky","year":"2007","unstructured":"Opotowsky AR, Mcwilliams JM, Cannon CP (2007) Gender differences in aspirin use among adults with coronary heart disease in the United States. J\u00a0Gen Intern Med 22:55\u201361","journal-title":"J Gen Intern Med"},{"key":"2975_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCOUTCOMES.115.001987","volume":"8","author":"K Smolina","year":"2015","unstructured":"Smolina K, Ball L, Humphries KH, Khan N, Morgan SG (2015) Sex disparities in post-acute myocardial infarction pharmacologic treatment initiation and adherence: problem for young women. Circ Cardiovasc Qual Outcomes 8:586\u2013592","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2975_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/heartjnl-2014-306463","volume":"102","author":"RY Khamis","year":"2016","unstructured":"Khamis RY, Ammari T, Mikhail GW (2016) Gender differences in coronary heart disease. Heart 102:1142\u20131149","journal-title":"Heart"},{"key":"2975_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ijcard.2016.02.015","volume":"209","author":"D De Smedt","year":"2016","unstructured":"De Smedt D, De Bacquer D, De Sutter J et\u00a0al (2016) The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology. Int J Cardiol 209:284\u2013290","journal-title":"Int J Cardiol"},{"key":"2975_CR12","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/bmj.322.7290.832","volume":"322","author":"J Hippisley-Cox","year":"2001","unstructured":"Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A (2001) Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 322:832","journal-title":"BMJ"},{"key":"2975_CR13","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1093\/eurheartj\/eht368","volume":"34","author":"C Koopman","year":"2013","unstructured":"Koopman C, Vaartjes I, Heintjes EM et\u00a0al (2013) Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998\u20132010. Eur Heart\u00a0J 34:3198\u20133205","journal-title":"Eur Heart J"},{"key":"2975_CR14","doi-asserted-by":"publisher","first-page":"e000298","DOI":"10.1136\/bmjgh-2017-000298","volume":"2","author":"SH Bots","year":"2017","unstructured":"Bots SH, Peters SAE, Woodward M (2017) Sex differences in coronary heart disease and stroke mortality: a\u00a0global assessment of the effect of ageing between 1980 and 2010. Bmj Glob Health 2:e298","journal-title":"Bmj Glob Health"},{"key":"2975_CR15","first-page":"1077","volume-title":"Arzneiverordnungsreport 2014. Aktuelle Daten, Kosten, Trends und Kommentare","author":"J Schaufler","year":"2014","unstructured":"Schaufler J, Telschow C (2014) Arzneiverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungsreport 2014. Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Berlin, Heidelberg, S\u00a01077\u20131092"},{"issue":"Suppl 2","key":"2975_CR16","first-page":"S59","volume":"60","author":"BM Bellach","year":"1998","unstructured":"Bellach BM, Knopf H, Thefeld W (1998) The German health survey. 1997\/98. Gesundheitswesen 60(Suppl 2):S59\u2013S68","journal-title":"Gesundheitswesen"},{"key":"2975_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/1099-1557(200005\/06)9:3<221::AID-PDS499>3.0.CO;2-P","volume":"9","author":"H Knopf","year":"2000","unstructured":"Knopf H, Melchert HU, Bertelsmann A (2000) Consumption of calcium antagonists: results of the German national health surveys. Pharmacoepidemiol Drug Saf 9:221\u2013233","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2975_CR18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00103-013-1667-8","volume":"56","author":"H Knopf","year":"2013","unstructured":"Knopf H, Grams D (2013) Medication use of adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:868\u2013877","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2975_CR19","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.302.21.2388","volume":"302","author":"JM Torpy","year":"2009","unstructured":"Torpy JM, Burke AE, Glass RM (2009) JAMA patient page. Coronary heart disease risk factors. JAMA 302:2388","journal-title":"JAMA"},{"key":"2975_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_37_17","volume":"18","author":"R Hajar","year":"2017","unstructured":"Hajar R (2017) Diabetes as \u201ccoronary artery disease risk equivalent\u201d: a historical perspective. Heart Views 18:34\u201337","journal-title":"Heart Views"},{"key":"2975_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/1874192401610010069","volume":"10","author":"A Gikas","year":"2016","unstructured":"Gikas A, Lambadiari V, Sotiropoulos A, Panagiotakos D, Pappas S (2016) Prevalence of major cardiovascular risk factors and coronary heart disease in a\u00a0sample of Greek adults: the Saronikos study. Open Cardiovasc Med\u00a0J 10:69\u201380","journal-title":"Open Cardiovasc Med J"},{"key":"2975_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-4419-9186-7_11","volume-title":"Advances in cross-national comparison. A European working book for demographic and Socio-economic variables","author":"H Brauns","year":"2003","unstructured":"Brauns H, Scherer S, Steinmann S (2003) The CASMIN educational classification in international comparative research. In: Hoffmeyer-Zlotnik J, Wolf C (Hrsg) Advances in cross-national comparison. A European working book for demographic and Socio-economic variables. Kluwer Academic \/ Plenum Publishers, New York, S 221\u2013244"},{"key":"2975_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, Mcnamara PM, Castelli WP (1983) Obesity as an independent risk factor for cardiovascular disease: a\u00a026-year follow-up of participants in the Framingham Heart Study. Circulation 67:968\u2013977","journal-title":"Circulation"},{"key":"2975_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00103-012-1662-5","volume":"56","author":"C Heidemann","year":"2013","unstructured":"Heidemann C, Du Y, Schubert I, Rathmann W, Scheidt-Nave C (2013) Prevalence and temporal trend of known diabetes mellitus: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:668\u2013677","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2975_CR25","volume-title":"Leitlinie: Koronare Herzkrankheit \/ Angina pectoris","author":"Deutsche Gesellschaft f\u00fcr Kardiologie","year":"1998","unstructured":"Deutsche Gesellschaft f\u00fcr Kardiologie (1998) Leitlinie: Koronare Herzkrankheit \/ Angina pectoris. https:\/\/leitlinien.dgk.org\/1998\/leitlinie-koronare-herzkrankheitangina-pectoris\/ . Zugegriffen: 17.10.2018"},{"key":"2975_CR26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00392-003-0960-1","volume":"92","author":"R Dietz","year":"2003","unstructured":"Dietz R, Rauch B (2003) Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung (DGK). Z\u00a0Kardiol 92:501\u2013521","journal-title":"Z Kardiol"},{"key":"2975_CR27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijcard.2007.12.115","volume":"133","author":"C Lahoz","year":"2009","unstructured":"Lahoz C, Mantilla T, Taboada M et al (2009) Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease. Int J Cardiol 133:336\u2013340","journal-title":"Int J Cardiol"},{"key":"2975_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.gheart.2015.11.003","volume":"12","author":"K Kotseva","year":"2017","unstructured":"Kotseva K, De Bacquer D, Jennings C et al (2017) Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in europe: results from 3 EUROASPIRE surveys, 1999\u20132013. Glob Heart 12:315\u2013322","journal-title":"Glob Heart"},{"key":"2975_CR29","volume-title":"Krankenversicherung in Deutschland","author":"Institut f\u00fcr Qualit\u00e4t und Wissenschaftlichkeit im Gesundheitswesen","year":"2015","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wissenschaftlichkeit im Gesundheitswesen (2015) Krankenversicherung in Deutschland. https:\/\/www.krankenkassen.de\/gesetzliche-krankenkassen\/beschwerde\/Institut-fuer-Qualitaet-und-Wirtschaftlichkeit-im-Gesundheitswesen\/ . Zugegriffen: 19.10.2018"},{"key":"2975_CR30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/heartjnl-2017-311429","volume":"103","author":"M Zhao","year":"2017","unstructured":"Zhao M, Vaartjes I, Graham I et\u00a0al (2017) Sex differences in risk factor management of coronary heart disease across three regions. Heart 103:1587\u20131594","journal-title":"Heart"},{"key":"2975_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/2047487312462148","volume":"21","author":"A Buja","year":"2014","unstructured":"Buja A, Boemo DG, Furlan P et al (2014) Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities? Eur J Prev Cardiol 21:222\u2013230","journal-title":"Eur J Prev Cardiol"},{"key":"2975_CR32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ahj.2007.11.036","volume":"155","author":"JT Nguyen","year":"2008","unstructured":"Nguyen JT, Berger AK, Duval S, Luepker RV (2008) Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart\u00a0J 155:862\u2013868","journal-title":"Am Heart J"},{"key":"2975_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","volume":"165","author":"J Lewey","year":"2013","unstructured":"Lewey J, Shrank WH, Bowry AD, Kilabuk E, Brennan TA, Choudhry NK (2013) Gender and racial disparities in adherence to statin therapy: a\u00a0meta-analysis. Am Heart\u00a0J 165:665\u2013678","journal-title":"Am Heart J"},{"key":"2975_CR34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/978-3-642-13380-0_46","volume-title":"Arzneiverordnungsreport 2010. Aktuelle Daten, Kosten, Trends und Kommentare","author":"V Coca","year":"2010","unstructured":"Coca V, Nink K (2010) Arzneiverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungsreport 2010. Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Berlin, Heidelberg, New York, S\u00a0933\u2013949"},{"key":"2975_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","volume":"117","author":"ZH Israili","year":"1992","unstructured":"Israili ZH, Hall WD (1992) Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 117:234\u2013242","journal-title":"Ann Intern Med"},{"key":"2975_CR36","volume-title":"Nationale VersorgungsLeitlinie Chronische KHK Version 1.11","author":"Bundes\u00e4rztekammer","year":"2011","unstructured":"Bundes\u00e4rztekammer, Kassen\u00e4rztliche Bundesvereinigung, Fachgesellschaften ADWM (2011) Nationale VersorgungsLeitlinie Chronische KHK Version 1.11. https:\/\/www.leitlinien.de\/mdb\/downloads\/nvl\/khk\/archiv\/khk-lang-1.11.pdf . Zugegriffen: 10.12.2018"},{"key":"2975_CR37","volume-title":"Untersuchung der medikament\u00f6sen Sekund\u00e4rpr\u00e4vention nach Myokardinfarkt auf Grundlage von GKV-Abrechnungsdaten","author":"S Mangiapane","year":"2008","unstructured":"Mangiapane S (2008) Untersuchung der medikament\u00f6sen Sekund\u00e4rpr\u00e4vention nach Myokardinfarkt auf Grundlage von GKV-Abrechnungsdaten. Technische Universit\u00e4t, Berlin"},{"key":"2975_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/1471-2458-12-730","volume":"12","author":"C Scheidt-Nave","year":"2012","unstructured":"Scheidt-Nave C, Kamtsiuris P, Gosswald A et al (2012) German health interview and examination survey for adults (DEGS) \u2013 design, objectives and implementation of the first data collection wave. BMC Public Health 12:730","journal-title":"BMC Public Health"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-02975-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-019-02975-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-02975-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T10:28:24Z","timestamp":1694946504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-019-02975-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-02975-1","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"11 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Knopf, M.A.\u00a0Busch, Y.\u00a0Du, D.\u00a0Grams, C.\u00a0Scheidt-Nave und G.\u00a0Sarganas geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}